SEOUL (Reuters) – The second of three South Korean expert panels recommended approval on Monday for Moderna’s coronavirus vaccine, based on its safety and efficacy in Phase 3 trials in the United States, the drug safety ministry said.
After the pharmaceutical panel’s backing, the next step is review by a third panel, before the ministry makes a final approval decision.
(Reporting by Hyonhee Shin; Editing by Clarence Fernandez)
NFL to open academy in Australia to identify and develop young prospects
Anze Kopitar scores in overtime, Kings beat Oilers 5-4 in Game 2 to tie series
Defending champion Golden Knights beat Stars 3-1 to take 2-0 series lead home to Vegas
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Lawyer says Iran rapper famous for songs after 2022 killing of Mahsa Amini sentenced to death
2 military horses that broke free and ran loose across London are in serious condition
Hungary’s Orbán urges European conservatives, and Trump, toward election victories at CPAC event
Ukraine is putting pressure on fighting-age men outside the country as it tries to replenish forces
The Latest | Israeli strikes in Rafah kill at least 5 as ship comes under attack in the Gulf of Aden
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
Tough new EPA rules would force coal-fired power plants to capture emissions or shut down
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
US births fell last year, marking an end to the late pandemic rebound, experts say
